104 related articles for article (PubMed ID: 24975969)
1. Morbidity and mortality of Iranian patients with hyper IgM syndrome: a clinical analysis.
Abolhassani H; Akbari F; Mirminachi B; Bazregari S; Hedayat E; Rezaei N; Aghamohammadi A
Iran J Immunol; 2014 Jun; 11(2):123-33. PubMed ID: 24975969
[TBL] [Abstract][Full Text] [Related]
2. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients.
Amirifar P; Mozdarani H; Yazdani R; Kiaei F; Moeini Shad T; Shahkarami S; Abolhassani H; Delavari S; Sohani M; Rezaei A; Hassanpour G; Akrami SM; Aghamohammadi A
Immunol Invest; 2021 Feb; 50(2-3):201-215. PubMed ID: 32116070
[No Abstract] [Full Text] [Related]
3. Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-Immunoglobulin M Syndrome in Iran.
Tafakori Delbari M; Cheraghi T; Yazdani R; Fekrvand S; Delavari S; Azizi G; Chavoshzadeh Z; Mahdaviani SA; Ahanchian H; Khoshkhui M; Behmanesh F; Aleyasin S; Esmaeilzadeh H; Jabbari-Azad F; Fallahpour M; Zamani M; Madani SP; Moazzami B; Habibi S; Rezaei A; Lotfalikhani A; Movahed M; Shariat M; Kalantari A; Babaei D; Darabi M; Parvaneh N; Rezaei N; Abolhassani H; Aghamohammadi A
Int Arch Allergy Immunol; 2019; 180(1):52-63. PubMed ID: 31117086
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
5. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
[TBL] [Abstract][Full Text] [Related]
6. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment.
Mohammadinejad P; Pourhamdi S; Abolhassani H; Mirminachi B; Havaei A; Masoom SN; Sadeghi B; Ghajar A; Afarideh M; Parvaneh N; Mirsaeed-Ghazi B; Movahedi M; Gharagozlou M; Chavoushzadeh Z; Mahdaviani A; Zandieh F; Sherkat R; Sadeghi-Shabestari M; Faridhosseini R; Jabbari-Azad F; Ahanchian H; Zandkarimi M; Cherghi T; Fayezi A; Mohammadzadeh I; Amin R; Aleyasin S; Moghtaderi M; Ghaffari J; Bemanian M; Shafiei A; Kalantari N; Ahmadiafshar A; Khazaei HA; Mohammadi J; Nabavi M; Rezaei N; Aghamohammadi A
J Investig Allergol Clin Immunol; 2015; 25(6):416-25. PubMed ID: 26817138
[TBL] [Abstract][Full Text] [Related]
7. Respiratory Complications in Patients with Hyper IgM Syndrome.
Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
[TBL] [Abstract][Full Text] [Related]
8. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome.
Aghamohammadi A; Imai K; Moazzami K; Abolhassani H; Tabatabaeiyan M; Parvaneh N; Nasiri Kalmarzi R; Nakagawa N; Oshima K; Ohara O; Nonoyama S; Rezaei N
J Investig Allergol Clin Immunol; 2010; 20(5):442-5. PubMed ID: 20945614
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
[TBL] [Abstract][Full Text] [Related]
10. The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management.
Yazdani R; Fekrvand S; Shahkarami S; Azizi G; Moazzami B; Abolhassani H; Aghamohammadi A
Clin Immunol; 2019 Jan; 198():19-30. PubMed ID: 30439505
[TBL] [Abstract][Full Text] [Related]
11. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
[TBL] [Abstract][Full Text] [Related]
12. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
[TBL] [Abstract][Full Text] [Related]
13. Study of patients with Hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature.
Karaca NE; Durandy A; Gulez N; Aksu G; Kutukculer N
Eur J Pediatr; 2011 Aug; 170(8):1039-47. PubMed ID: 21274562
[TBL] [Abstract][Full Text] [Related]
14. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
[TBL] [Abstract][Full Text] [Related]
15. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
[TBL] [Abstract][Full Text] [Related]
16. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
[TBL] [Abstract][Full Text] [Related]
17. Onychomadesis in a patient with immunoglobulin class switch recombination deficiency.
Safari M; Rezaei N; Hajilooi M; Aghamohammadi A; Pan-Hammarstrom Q; Hammarstrom L
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):41-4. PubMed ID: 18322312
[TBL] [Abstract][Full Text] [Related]
18. Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects.
Jhamnani RD; Nunes-Santos CJ; Bergerson J; Rosenzweig SD
Front Immunol; 2018; 9():2172. PubMed ID: 30319630
[TBL] [Abstract][Full Text] [Related]
19. Mortality and morbidity in common variable immunodeficiency.
Aghamohammadi A; Pouladi N; Parvaneh N; Yeganeh M; Movahedi M; Gharagolou M; Pourpak Z; Rezaei N; Salavati A; Abdollahzade S; Moin M
J Trop Pediatr; 2007 Feb; 53(1):32-8. PubMed ID: 17166933
[TBL] [Abstract][Full Text] [Related]
20. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity.
Fazel A; Kashef S; Aleyasin S; Harsini S; Karamizadeh Z; Zoghi S; Flores SK; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2017; 45(1):82-86. PubMed ID: 27789066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
